InvestorsHub Logo
icon url

KrakenTaken

11/28/16 4:36 PM

#27122 RE: High_Profits #27112

OLD J FELLER HOLDINGS LTD!!!
icon url

High_Profits

11/28/16 4:39 PM

#27123 RE: High_Profits #27112

*** WOW *** in respect to Emilia's Licensed Intellectual Property to be developed and commercialized worldwide in the topical treatment of Psoriasis in humans with OWC's Product and upon the successful achievement of the trial, Emilia will grant OWC an exclusive, worldwide, transferable, royalty-bearing license, with the right to grant sublicenses, to use, sell and commercially exploit the Emilia Intellectual Property (the "License").
icon url

cjstocksup

11/28/16 11:21 PM

#27212 RE: High_Profits #27112

Excellent DD post.
icon url

cjstocksup

11/29/16 9:56 AM

#27257 RE: High_Profits #27112

OWCP NEW 8K OUT

Item 1.01. Entry Into A Material Definitive Agreement.

On November 27, 2016, OWC Pharmaceutical Research Corp. (the "Registrant" or "OWCP") and its wholly-owned Israeli subsidiary, One World Cannabis Ltd (OWC Ltd") entered into a license agreement (the "License Agreement") with Emilia Cosmetics Ltd., a company organized under the laws of the State of Israel ("Emilia"), a world-leading company in the field of development, production, manufacturing and packaging of health and beauty products including for treatment of human skin disease. OWCP and OWC Ltd are sometimes referred to collectively as "OWC."

Prior to entering into the License Agreement, the Parties conducted a Development and Evaluation Program (as defined in the License Agreement) for the development of a specific product comprising Emilia's formulation with certain medical cannabis extract provided by OWC Ltd for topical treatment of Psoriasis ("OWC's Product").

Pursuant to the License Agreement, a copy of which is attached hereto as Exhibit 10.19, Emilia has granted a limited license to OWC with respect to Emilia's Licensed Intellectual Property to be developed and commercialized worldwide in the topical treatment of Psoriasis in humans with OWC's Product and upon the successful achievement of the trial, Emilia will grant OWC an exclusive, worldwide, transferable, royalty-bearing license, with the right to grant sublicenses, to use, sell and commercially exploit the Emilia Intellectual Property (the "License"). In consideration for the License, from and after the first commercial sales of the Licensed Product, OWC shall pay to Emilia a royalty at the rate of ten (10%) percent of net sales during the period of time beginning upon the first commercial sale and ending ten (10) years thereafter (the "Royalty Term"). In the event the sale of the Licensed Product during the Royalty Term reaches the minimum sales targets mutually agreed by the Parties as set forth in the License Agreement, the Royalty Term will extend to an additional five (5) year term.
The foregoing descriptions of the License Agreement are qualified in their entirety by reference to the full text of thereof, a copy of which is attached hereto as Exhibit and which is incorporated herein in its entirety by reference.

icon url

Hercules1

11/30/16 1:03 PM

#27488 RE: High_Profits #27112

This deal is as big as it gets.

OWCP will have worldwide exposure fairly rapidly.

OWCP is doing everything right.
icon url

realnewb

12/22/16 7:50 AM

#28993 RE: High_Profits #27112

So much going on here lol
icon url

Eagle1

01/13/17 7:53 PM

#35278 RE: High_Profits #27112

OWCP: with no toxic debt, and no debt and serious pharmaceutical properties that owcp has, the sky is the limit!

I see multi multi dollars next week.

No shares available$ but demand is extremely high!


Watch this CONTINUE to move up like a Rocket!

Eagle1

icon url

Hercules1

01/21/17 10:45 PM

#40132 RE: High_Profits #27112

It is this deal with Emilia that gives our products rapid global exposure.

This is absolutely huge.
icon url

Hercules1

01/26/17 10:36 AM

#42131 RE: High_Profits #27112

This deal is absolutely massive.

It is actually beyond massive.

It means near instant global exposure for our products.


It doesn't get any better than this.